SEC Form 4 · accession 0001209191-17-034532
REVA Medical, Inc. · RVA:AX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Regina E Groves
Officer — Chief Executive Officer
Period of report
May 19, 2017
Accepted (ET)
May 22, 2017 · 8:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496268
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 19, 2017 | A | 29,250 | $0.00 | A | 120,609 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $6.71 | May 19, 2017 | A | 58,500 | A | — | May 19, 2027 | Common Stock | 58,500 | 58,500 | D |
Explanation of responses
- F1Restricted stock units convert into common stock on a one-for-one basis. These restricted stock units shall vest annually on the anniversary date of the grant (May 19), with the first vesting occurring on May 19, 2018, at the rate of 33.3% annually, until fully vested.
- F225% of the shares vest on May 19, 2018, with the remaining shares vesting at 2.08333% per month thereafter until fully vested.